Detalles de la búsqueda
1.
IL-9 exerts biological function on antigen-experienced murine T cells and exacerbates colitis induced by adoptive transfer.
Eur J Immunol
; 50(7): 1034-1043, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32130733
2.
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 19(7): 916-929, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29908991
3.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(6): 822-835, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27132212
4.
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 156(2): 301-10, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26975189
5.
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.
Breast Cancer Res Treat
; 156(2): 319-30, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26993131
6.
IL-9 promotes IL-13-dependent paneth cell hyperplasia and up-regulation of innate immunity mediators in intestinal mucosa.
J Immunol
; 182(8): 4737-43, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19342650
7.
Expression of tumor-associated antigens in breast cancer subtypes.
Breast
; 49: 202-209, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31869767
8.
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer.
Clin Cancer Res
; 26(7): 1725-1735, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732522
9.
Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic.
ESMO Open
; 3(5): e000384, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30094070
10.
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.
ESMO Open
; 2(5): e000203, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29177094
11.
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patients.
Asia Pac J Clin Oncol
; 13(5): e212-e223, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27519286
12.
The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients.
Lung Cancer
; 101: 137-144, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27794402
13.
Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non-Small Cell Lung Cancer: A Phase I Dose Escalation Study.
J Thorac Oncol
; 11(12): 2208-2217, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27544054
14.
MAP kinase activation by interleukin-9 in lymphoid and mast cell lines.
Oncogene
; 22(12): 1763-70, 2003 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-12660812
15.
Development of a Quantitative Real-Time RT-PCR Assay for the Detection of MAGE-A3-Positive Tumors.
J Mol Diagn
; 17(4): 382-91, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25986000
16.
A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors.
J Immunother
; 38(8): 311-20, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26325375
17.
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer.
J Thorac Oncol
; 10(10): 1458-67, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26309191
18.
A calcium-activated chloride channel blocker inhibits goblet cell metaplasia and mucus overproduction.
Novartis Found Symp
; 248: 150-65; discussion 165-70, 277-82, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12568493
19.
Isolation of Ixodes ricinus salivary gland mRNA encoding factors induced during blood feeding.
Am J Trop Med Hyg
; 66(3): 225-33, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12139212
20.
Tumor mouse model confirms MAGE-A3 cancer immunotherapeutic as an efficient inducer of long-lasting anti-tumoral responses.
PLoS One
; 9(5): e94883, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24830315